For the year ending 2025-12-31, WHWK made $7,145K in revenue. -$20,492K in net income. Net profit margin of -286.80%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 7,145 | |||
| Selling, general and administrative | 29,822 | |||
| Research and development | 90,963 | |||
| Restructuring charges | 0 | |||
| Cost of goods sold | 760 | |||
| Total operating expenses | 121,545 | |||
| Loss from operations | -114,400 | |||
| Gain on sale of business | 87,266 | |||
| Foreign exchange gain (loss) | 5 | |||
| Other income | 302 | |||
| Interest income | 6,231 | |||
| Interest expense | 0 | |||
| Total other income (expense), net | 93,804 | |||
| Loss before income tax expense | -20,596 | |||
| Income tax expense | 0 | |||
| Net loss | -20,596 | |||
| Unrealized gain (loss) on investments, net of tax | 104 | |||
| Comprehensive loss | -20,492 | |||
| Basic EPS | -0.33 | |||
| Diluted EPS | -0.33 | |||
| Basic Average Shares | 61,886,765 | |||
| Diluted Average Shares | 61,886,765 | |||
Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. (WHWK)